Number of the records: 1  

Synthesis, Inhibitory Activity, and in Silico Modeling of Selective COX-1 Inhibitors with a Quinazoline Core

  1. 1.
    0547414 - ÚEB 2022 RIV US eng J - Journal Article
    Dvořáková, Marcela - Langhansová, Lenka - Temml, V. - Pavičić, Antonio - Vaněk, Tomáš - Landa, Přemysl
    Synthesis, Inhibitory Activity, and in Silico Modeling of Selective COX-1 Inhibitors with a Quinazoline Core.
    ACS Medicinal Chemistry Letters. Roč. 12, č. 4 (2021), s. 610-616. ISSN 1948-5875
    R&D Projects: GA MŠMT(CZ) LTC17048
    Institutional support: RVO:61389030
    Keywords : Cyclooxygenase * docking * inhibitor * quinazoline * selectivity
    OECD category: Organic chemistry
    Impact factor: 4.632, year: 2021
    Method of publishing: Open access
    http://doi.org/10.1021/acsmedchemlett.1c00004

    Selective cyclooxygenase-1 (COX-1) inhibition has got into the spotlight with the discovery of COX-1 upregulation in various cancers and the cardioprotective role of COX-1 in control of thrombocyte aggregation. Yet, COX-1-selective inhibitors are poorly explored. Thus, three series of quinazoline derivatives were prepared and tested for their potential inhibitory activity toward COX-1 and COX-2. Of the prepared compounds, 11 exhibited interesting COX-1 selectivity, with 8 compounds being totally COX-1-selective. The IC50 value of the best quinazoline inhibitor was 64 nM. The structural features ensuring COX-1 selectivity were elucidated using in silico modeling.
    Permanent Link: http://hdl.handle.net/11104/0323654

     
    FileDownloadSizeCommentaryVersionAccess
    2021_Dvorakova_ACS MEDICINAL CHEMISTRY LETTERS_610.pdf14.9 MBOtheropen-access
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.